↓ Skip to main content

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd001797.pub3
Pubmed ID
Authors

Filip Eftimov, John B Winer, Marinus Vermeulen, Rob de Haan, Ivo N van Schaik

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This review was first published in 2002 and has since been updated, most recently in 2013.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
United States 1 1%
South Africa 1 1%
Unknown 93 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 22%
Other 13 13%
Student > Ph. D. Student 13 13%
Researcher 11 11%
Student > Bachelor 9 9%
Other 15 15%
Unknown 15 15%
Readers by discipline Count As %
Medicine and Dentistry 40 41%
Nursing and Health Professions 10 10%
Neuroscience 5 5%
Agricultural and Biological Sciences 5 5%
Social Sciences 3 3%
Other 13 13%
Unknown 21 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2014.
All research outputs
#10,024,020
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#8,595
of 8,923 outputs
Outputs of similar age
#160,704
of 237,634 outputs
Outputs of similar age from Cochrane database of systematic reviews
#163
of 180 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,634 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 180 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.